Q3 2013

Filed Nov 14, 2013 · 10-Q · 45 days after period end · 0001477932-13-005502

Q3 2013 · 10-Q

Revenue

$277.41K

+333.6% vs Q3 2012

Net Income

-$129.04K

N/M vs Q3 2012

EPS Diluted

$0.00

— vs Q3 2012

Gross Profit$277,410N/M

Operating Cash Flow

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$277.41K	$63.97K	$344.31K	—
Net Income	-$129.04K	-$160.97K	-$1.94K	-$4.85K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR